Simpson Thacher represented the underwriters in the initial public offering and Regulation S offering by Kaisa Property Holdings Limited (“Kaisa Property”). Kaisa Property offered an aggregate...
Kaisa Property’s $42.1 Million Initial Public Offering
Weidai’s $45 Million Initial Public Offering
Simpson Thacher represented the underwriters, Morgan Stanley, Citigroup and AMTD Tiger, in connection with the initial public offering and listing on the New York Stock Exchange...
ICG Strategic Equity Advisors’ Acquisition of private equity portfolio investments held by Standard Chartered Private Equity and its affiliates in India
Khaitan & Co advised ICG Strategic Equity Advisors LLC (ICGSE) on the deal ICG Strategic Equity, the private equity arm of the US-based Intermediate Capital Group,...
Quad-C’s Investment in Canadian IT staffing firm S.i. Systems
Khaitan & Co advised Quad-C Management, Inc. (Quad-C) on the Indian leg of the transaction. Quad-C Management, Inc. (“Quad-C”), a leading middle market private equity firm,...
TuanChe’s $38 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati represented TuanChe in the offering and listing TuanChe Limited (NASDAQ: TC), a leading omni-channel automotive marketplace in China, priced its initial...
Vedant Fashions Private Limited’s Merger with Rainbow Iron and Steel Suppliers Private Limited
Khaitan & Co advised Vedant Fashions Private Limited on the deal Vedant Fashions Private Limited, the parent enterprise to Manyavar, Mohey and Mebaz, is a pioneer...
CM Seven Star’s $454 Million Acquisition of Kaixin Auto Group
Simpson Thacher is representing Kaixin Auto Group (“Kaixin”) in connection with its acquisition by CM Seven Star Acquisition Corporation (“CM Seven Star”). Skadden represented Renren Inc.,...
Revance’s $260 Million China Market License Agreement with Fosun Pharma for RT002
O’Melveny represented Silicon Valley-based biotechnology company Revance Therapeutics, Inc. in a licensing agreement with Shanghai Fosun Pharmaceutical Industrial Development Co. Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology...
China Evergrande’s $1.8 Billion High-Yield Senior Notes Offering
Davis Polk advised the initial purchasers of a Regulation S offering of high-yield notes by Scenery Journey Limited (a subsidiary of China Evergrande Group) of $565...
CNFinance Holdings Limited on Its Initial Public Offering
Davis Polk advised CNFinance Holdings Limited on its SEC-registered initial public offering of 6,925,000 American Depositary Shares, including the partial exercise of the underwriters’ option to...
Heineken’s Strategic Partnership with China Resources
Davis Polk is advising Heineken N.V. in connection with its entry into definitive agreements with China Resources Enterprise (“CRE”) and China Resources Beer (Holdings) Co. Ltd....
Innovent Biologics, Inc.’s $403.1 Million Initial Public Offering
Davis Polk advised the underwriters and joint global coordinators in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering...